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I HAVE BEEN interested in the malabsorption syndromes for a long time and
one of the fascinations of a continued interest over the years is to watch the
emphasis change as new knowledge is added and old problems are solved. When
I reviewed the subject in 1960 the classical idea that all the signs and symptoms
of the malabsorption syndromes were due to failure of absorption of essential
substances still held the field, but even then this was difficult to sustain. It was
held, for example, that the dermatitis, glossitis and cheilosis that occurred in some
patients, were due to faulty absorption of B vitamins and yet it was known that
with one or two notable exceptions the absorptive capacity of the small intestine
for the water soluble vitamins was enormous, and that even in the presence of
gross steatorrhoea enough could be absorbed to satisfy the body's needs. Gradually,
we have had to come to realise that malabsorption is only one facet of the problem,
even if it is the easiest to recognise.
In the presence of gross disorganisation of the small intestine not only are
substances poorly absorbed but the normal losses by secretion and exudation into
the lumen of the gut may be greatly increased either by direct seepage into the
lumen or as a result of increased exfoliation of cells from the mucosal wall.
Creamer and Croft (1970) have estimated that in normal man 60,000,000 cells
may be lost daily from the small intestine together with 80 gms. of protein. Sixteen
per cent of the protein lost is contained in the exfoliated cells. The greater quantity
of this, of course, is digested and reabsorbed but in coeliac disease the loss of
cells and protein may be increased six-fold and may contribute significantly to
the hypoproteinaemia which occurs. It is known that not only protein but also
iron and vitamin B12 are lost both by exfoliation and exudation and it may well
be that there is an increased loss of many other essential substances when the
mucosa is damaged.
Moreover, the patient with malabsorption is at a double disadvantage because
substances which are lost into the lumen of the gut are likely to be less well-
absorbed than in normal persons. Finally, in coeliac disease and other conditions
associated with malabsorption, failure of absorption and increased loss into the
lumen of the bowel may not be the only factors of importance. It is quite possible
that abnormal substances, the result of faulty digestion or bacterial action, may
be absorbed and give rise to far-reaching effects. Perhaps the first pointer to this
came from an observation by England, French and Rawson (1960) some years ago.
They studied a patient with Whipple's disease and a light sensitive dermatitis who
was found to be excreting abnormal porphyrins in the stools. Treatment with
antibiotics abolished the porphyrins from the stools and cured the dermatitis. The
exact reason for the improvement remained uncertain but it could have been due
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For the clinician, the observation of Dickie (1950) that the removal of wheat and
rye protein from the diet of children with coeliac disease will cure the patient
still holds the centre of the stage. Much fundamental research stems from this
single fact but it is chastening to realise that in spite of all efforts the exact nature
of the defect in the small intestine and the way in which this normal dietary
protein exerts its damaging effect is still unknown.
In 1959 Fraser and his colleagues showed that a peptic/tryptic hydrolysate of
gluten was toxic to patients with coeliac disease, but if this hydrolysate was further
digested by fresh hog intestinal mucosa the product was no longer capable
of damaging the intestinal mucosa and inducing malabsorption in coeliac
patients. As a result of these experiments it was concluded that coeliac disease
was due to the congenital absence of a peptidase from the intestinal mucosa
(Fraser et al, 1959). Unhappily, sixteen years later this peptidase still eludes all
efforts to find it. Perhaps the most damaging blow to the supporters of the "absent
peptidase" theory of the aetiology of coeliac disease was struck by Douglas and
Booth (1970). They showed that the activity of leucyl-leucine hydrolase was
depressed in the mucosa of untreated coeliac patients but after treatment with
a gluten-free diet or even after treatment with steroids while the patients continued
to take gluten in the diet, no difference in activity between the coeliac patients and
the normal controls could be found.
However, the absent peptidase theory cannot be disposed of as easily as that.
Amino-acids are absorbed by more than one system and even the di- and tripeptides
can be absorbed into the mucosal cell in several different ways, and, as Matthews
(1971) has pointed out, the only single biochemical lesion which could impair the
absorption of protein would be a failure of release of the amino acids produced
by digestion from the mucosal cell into the bloodstream. It is known that amino
acid transport defects, even when they involve several amino acids, do not produce
any clinical signs directly referable to the impairment of protein absorption. The
mucosal peptidases are so numerous and have so many overlapping specificities
that a single defective peptidase might be very difficult to detect by present assay
methods.
The second major hypothesis to explain gluten sensitivity invokes a disturbance
of immune reactions and stems from two observations. The first was the observation
that precipitating antibodies to gluten or to its derivatives can be found in the
serum of some patients with coeliac disease (Berger, 1958), and, the second, was
the demonstration that treatment with steroids could bring about improvement
in these patients even if they continued to eat a diet that contained gluten (Katz
et al, 1968). Personally, I believe that the second prop in the argument is not
necessarily secure because there could be other reasons for the effects of steroids,
for example they induce non-specific changes in the permeability of cells and they
are known to alter the activity of lysozymes Nonetheless, in recent years our
understanding of the immune defences of the gut has increased and this has lent
impetus to a study of the disturbance that occurs in intestinal disease. We know,
for example, that the plasma cells of the gut chiefly synthesize IgA which is
released into the sub-epithelial pool as a 7s monomer. Some of this is transported
across the gut epithelium becoming dimerised in the process and to this dimer
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IgA thus formed reached the lumen of the gut and it differs from 7s IgA in two
important ways. The secretory IgA is resistant to normal intestinal pH and enzymes
and it can fix complement and damage the lipoid membrane of bacteria (Hobbs,
1971).
The results of studies of the abnormalities of the immune globulins which are
present in patients with coeliac disease have been conflicting and the picture has
been complicated still further by the fact that patients with either primary
deficiency of immune globulins or a deficiency secondary to other disease such as
leukaemia, often have maiabsorption. Both deficiency of IgA and IgM and an
increase in IgA and IgM have been described. Many of the results are conflicting
and it seems to depend largely on whether the author has been studying the serum,
the mucosal wall of the intestine or the intestinal secretions within the lumen itself.
Moreover the differences between coeliac disease and patients with other diseases
of the gut are not absolutely clear cut. The changes seem to depend on whether or
not the patient has been under treatment with a gluten-free diet. Recently, Hobbs
and his colleagues, summarised what is known of the subject. In their view the
only significant difference between patients with coeliac disease and those with
other diseases involving the small intestine was that patients with coeliac disease.
whatever the levels of IgA or 1gM in their plasma, showed an increase in the
density of jejunal plasma cells containing IgM while the density of plasma cells
containing IgA was either normal or decreased (Hobbs et al, 1969).
It is known that antibodies of the IgA type provide the main defence of the
gut against virus infection. Beale and his colleagues (1971) have shown that whereas
coeliac patients can produce normal IgG antibodies in response to a challenge
with tetanus toxoid, they produce subnormal amounts of IgA in response to an
oral dose of poliomyelitis vaccine. Beale suggests that in coeliac disease the ability
of the patient to produce TgA antibodies is depressed. In its place IgM antibodies
are produced and these, unlike the IgA antibodies, are capable of damaging the
intestinal mucosa (Beale et al, 1971).
The exact relationship of the relative deficiency in the synthesis of IgA to the
aetiology of coeliac disease remains unclear. Certainly, enough evidence has already
accumulated to show that a quantitative decrease in IgA does not occur in every
patient. Perhaps in the future it will be more profitable to look at the quality of
the IgA which is produced and to follow up the work which has been done on
patients with giardiasis and nodular lymphoid hyperplasia of the gut. In some of
these, although the levels of IgA and IgM have been normal, the IgM has been
found to be of poor quality and inadequate to protect the wall of the gut from
the parasite (Hobbs, 1971).
Personally, I think it may be some time before we understand fully the cause of
the gluten sensitive enteropathy. The one unassailable fact is that one chemical
compound or a small group of chemical compounds have been shown to do the
damage while as far as we know, once the mucous membrane has been restored
to normal, all other substances present in the food are harmless. This being so, it
seems odd to me that a failure of the normal IgA immune response, which one
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be so restrictive in its action.
In the last five years we have learnt a great deal about the processes of digestion
that go on within the mucosal cell of the small intestine and it may yet be shown
that the two hypotheses, on the one hand the alleged absence of a peptidase, on
the other the abnormalities in the immune response, may yet be closely inter-
related and that the prime cause of the immunological abnormality is a disturbance
of the chemistry within the cells of the mucous membrane itself.
Whatever its cause it is a fact that immuneparesis does occur in some patients
with the coeliac syndrome and as Austad and his colleagues have emphasised there
is a profound disturbance of the lymphoreticular system (Austad et al, 1967). There
may be splenic atrophy with Howell Jolly bodies in the red blood cells and an
increased red cell survival time. There is hypoplasia of the peripheral lymph
nodes and an increase in size of the nodes in the mesentery, and the lamina propria
of the gut, and even the epithelial cells may be infiltrated with lymphocytes.
Austad and his colleagues have postulated that the immunological insufficiency may
be the result of a prolonged overactivity of antibody formation aggravated in some
way by the sensitivity to gluten. Whatever its cause there is no doubt that
immuneparesis does occur and it is perhaps of more than theoretical interest that
it also occurs in Hodgkin's disease and other lymphomata. It is now well recognised
that lymphomata occur more often in patients with the coeliac syndrome than in
the population at large, and Whitehead (1968) has suggested that in these patients
there may be a progressive hyperplasia of the lymphoreticular system with a
gradual appearance of abnormal reticulum cells ending in the clinical manifestation
of reticulosarcoma. He believes that this may be an expression of an auto-immune
process that goes on to malignancy, and that it can be compared with the reticuloses
that complicate some cases of Hashimoto's disease of the thyroid.
The incidence of carcinoma, especially of the foregut, is also higher in patients
with coeliac disease than in the general population and I suppose it is possible
that here, too, the development of an immuneparesis may predispose to the neo-
plastic change.
There is another aspect of the clinical picture of coeliac disease which may be
linked to the immuneparesis. Everybody who has studied patients with steatorrhoea
has encountered a few with a lesion of the spinal cord which can progress despite
full supportive therapy including vitamin B12, a gluten-free diet and steroids.
I have had five totally unexplained cases and Cooke and Smith in 1966 published
an account of sixteen. Their patients, eleven male and five female, were aged 26
to 68 at the onset of the neropathy. The main changes were a sensory ataxia
chiefly involving the legs, a peripheral neuropathy, posterior column loss, muscle
weakness but little wasting and no tenderness. Three of the patients had cerebellar
dysfunction and five had unexplained transient attacks of loss of consciousness.
In ten the neuropathy had been steadily progressive, nine had died and in four the
neuropathy was the main cause of death. In another four it was a major con-
tributory factor. It is of interest that one died of a reticulosarcoma. At autopsy
in these patients the pathological changes are widespread and diffuse involving
the cortex, the anterior horn cells and the spinal cord. There is patchy atrophy and
loss of cells and focal areas of demyelination. The changes most closely resemble
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neoplastic disorders.
As I have mentioned, one patient in Cooke's series died of a reticulosarcoma
and there are at least two other cases in the literature in which this has happened.
One, reported by Brain, Croft and Wilkinson in 1965, had steatorrhoea and a
reticulosarcoma with neurological signs resembling motor neurone disease and
another, published by Missen in 1966, with steatorrhoea and a malignant lympoma
of the intestine suffered from cerebellar cortical dysfunction towards the end of
his life. This is a surprising association and for some time I have been wondering
whether these facets of the clinical picture of the coeliac syndrome, the immune-
paresis, the increased incidence of malignant change and the progressive and lethal
neuropathy might be related. Nobody knows the cause of the immuneparesis
but once established might it not allow a slow virus to attack the central nervous
system or perhaps even allow the development of a neoplasm which as Missen,
himself, has suggested might further impair the immune defence by massive replace-
ment of the lyinphoreticular system by malignant cells and thus lay the way open
for a neurotropic virus. Clearly, the neuropathy of the coeliac syndrome should be
a fruitful field for study. It is certainly not due to a deficiency of any known
vitamin. It can be progressive and lethal in spite of all attempts at treatment and
it is associated with a neoplasm more commonly than seems possible by chance
alone. It remains a complete enigma.
The next aspect of the malabsorption syndromes that I wish to consider today
is the derangement of function that accompanies the short gut syndrome. The
pattern of ileal dysfunction which follows resection of the bowel is particularly
interesting because it has led to a better understanding of much of the patho-
physiology of malabsorption but here also there are some unsolved problems.
Borgstrom and his co-workers showed that after a test meal not only sugar and
protein but also fat are almost completely absorbed in the first metre of the
jejunum (Borgstrom et al, 1957). This being so it is perhaps surprising that the
loss of part of the small intestine should be associated with such a profound
disturbance of function. However, the situation is not always too desperate. It is
known that 70 per cent of the small intestine can be resected without steatorrhoea
if the terminal ileum and ileocaecal valve are preserved. If these are resected the
position is very much worse and a loss of just over 50 per cent will lead to
persistent diarrhoea and steatorrhoea.
The simple sugars and many water soluble substances are absorbed in the high
small bowel and proteins, fats and fat soluble vitamins are absorbed in the upper
and mid-small bowel, but cholesterol, vitamin B12 and the bile salts are chiefly
absorbed by an active transport system selectively localised to the ileum. When
the lower small bowel is resected the sites of active transport of these substances
are lost and it is the failure of the absorption of bile salts and consequent bile
salt deficiency that explains why steatorrhoea is much more prone to occur after
ileal resections than after resections of the jejunum.
Under normal condition 98 per cent of the bile salts that are secreted into the
lumen of the intestine are reabsorbed and find their way back to the liver via
the portal stream for recirculation in the bile. The bile salts are recirculated several
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from cholesterol just equals the loss of bile acids in the faeces. Anything that
interrupts the enterohepatic circulation of bile salts will lead to a rapid depletion
of the pool with consequent failure of the micellar phase of fat absorption. The four
main causes of depletion of the pool of circulating bile acids are obstructive
jaundice, the contaminated bowel syndrome in which bacteria bring about excessive
deconjugation of the bile salts, the binding of bile salts within the lumen of the gut
by ion-exchange resins such as cholestyramine, and resection of the ileum or the
short gut syndrome. Following a resection of the ileum loss of the active absorptive
site for bile salts causes them to reach the colon in larger quantities than normal
where they block the active absorption of water and electrolytes from the bowel and
make the diarrhoea worse (Mekhjian et al, 1968).
If the resection of the bowel is complicated by the presence of strictures, blind
loops of gut or fistulae, bacteria will flourish and abnormal deconjugation of even
those bile salts that remain will occur. This will deplete the pool of bile salts still
further and make it even more difficult to form the micelles necessary for fat
absorption. The damaging effect of depletion of the bile salt pool is not limited
to the absorption of fat. There is some evidence that when free bile acids are
present in excess within the lumen of the gut they interfere also with the active
transport of sugars and amino acids although the exact way in which they do this
remains unknown (Baraona et al, 1968).
In the absence of gross bacterial contamination jejunectomy does not produce
a continuing clinical defect in the transport of proteins, sugars or electrolytes
because the active transport sites for these substances are present throughout the
small intestine. Similarly, the removal of the ileum does not produce a major
primary defect in absorption unless changes in motility, or abnormal bile salt
loss with consequent steatorrhoea supervene.
Usually there is plenty of reserve capacity for active absorption but sometimes
it is possible to saturate a limited active transport system. For example, after
massive resection of the gut a solute overload at meal times can lead to tiresome
postprandial diarrhoea which takes months to subside.
It would be very useful if passive transport played a greater part in normal
absorption but unhappily its place is limited. Sugars, electrolytes, amino acids, fatty
acids, pyrimidines, bile salts, cholesterol, vitamin B12 and folic acid all require
an active transport system. A notable and useful exception involves the medium
chain triglycerides which are absorbed largely by passive diffusion. Many sub-
stances that are primarily absorbed by an active process can also be absorbed in
small amounts by passive diffusion and, if the body's requirements are small,
enough may be absorbed by this route. This probably applies to some vitamins,
trace elements and drugs.
The main cause of failure of absorption in the short gut syndrome is the loss
of specialised absorptive sites especially those localised to the ileum, but there
are also some secondary effects of resection of the gut which contribute to the
disturbance in function. The worst of these is the alteration in gastric secretion
and the disturbance of gastric and intestinal motility that develops. In man and
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occurs.
The aetiology of the gastric hypersecretion is still in doubt. It is more marked
after proximal than distal resections. It is possible, I suppose, that the small bowel
remnant elaborates a gastric secretagogue. It has been shown that patients who
have had a portacaval shunt secrete abnormal amounts of acid and that this
is caused possibly by a secretagogue elaborated in the jejunum, but after resection
of the bowel the excessive secretion of acid from the stomach seems more likely
to be due to the loss of an inhibitor of gastric secretion, an enterogastrone. It is
interesting that both serotonin and histaminase are localised in the upper small
intestine and if the secretion of either of these were reduced gastric hypersecretion
might result.
In 1956 Reynell and Spray in Oxford showed that after massive resection of the
small gut in rats there was a marked increase in motility and a shortened transit
time. This effect, in contrast to the gastric hypersecretion, is more marked if the
distal small bowel is removed. Its cause is unknown but here, too, the loss of an
inhibitory hormone could be responsible.
In coeliac disease in particular abnormalities of function resulting from the loss
of gastrointestinal hormones are probably much more common than we realise.
It is self-evident if you stop to think about it. In the gluten enteropathy the villi
are destroyed, the mucosa is flattened, the brush border has vanished and the
epithelial cells are debased and distorted. When this occurs we are quite ready
to accept that there will be a failure of the intramural phase of digestion. On the
other hand the concept that there must also be a loss of production of any
intestinal hormones which are ebalorated in the mucosal cells or in the brush border
is relatively new and is still not widely accepted.
In the past year or so evidence has been accumulating that loss of these gastro-
intestinal hormones may indeed be important. In normal persons the physiological
stimulus for the secretion of pancreozymin is the presence of amino-acids in the
lumen of the upper intestine. In 1969 DiMagno, Go and Summerskill showed that
in patients with coeliac disease the perfusion of the jejunum with amino-acids
produced a subnormal secretion of pancreatic enzymes. They deduced that this
was because the amino-acids present within the lumen had led to the release of
abnormally small amounts of pancreozymin from the intestine. If the pancreozymin
was injected parenterally the outflow of enzymes from the pancreas was normal.
Similarly, Low-Beer and his colleagues (1971) from Bristol have demonstrated
inertia of the gall bladder in response to a fatty meal in patients with coeliac
disease. They have suggested that the failure of the gall bladder to contract resulted
from an impairment of the release of cholycystokinin, and they postulate that the
steatorrhoea in coeliac disease may be aggravated by a delay in the secretion of
bile salts and pancreatic enzymes after a meal, which contributes to the failure of
micelle formation. In this context it is interesting to recall that patients with the
short gut syndrome and ileal dysfunction have a much higher incidence of gall
stones than the population at large, and it may be that bile is sequestered in the
biliary tree because of gall bladder inertia resulting from the loss of an intestinal
activator.
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especially those who have had a resection of the small bowel are more prone than
the general population to the development of stones not only in the gall bladder
but also in the kidneys. In the United States the incidence of renal stones in
patients in hospital is estimated to be about 1: 1,000 but Gel!zayd and his
colleagues in 1968 reviewed 885 patients with bowel disease and found the incidence
of nephrolithiasis in them to be 7.2 per cent.
Initially, it was thought that the increased incidence of renal stones was caused
by the fact that many of these patients lose quantities of water, sodium and
bicarbonate into the gut and as a result secrete an acid urine of low volume which
would favour stone formation, but in 1970 Hofmann and co-workers described
two patients with previous small bowel resection and nephrolithiasis who had
hyperoxaluria. In 1971, Dowling, Rose and Suter reported eleven patients with
ileal dysfunction, eight of whom had hyperoxaluria and three of whom had calcium
oxalate stones in the renal tract.
Several hypotheses have been put forward to explain the hyperoxaluria and in
1972 at the meeting of the British Society for Gastroenterology at Aviemore
Chadwick, Modha and Dowling produced an interesting paper that did much to
settle the dispute. It has been suggested that bile salt glycine spilling into the
colon because of ileal dysfunction was deconjugated by bacteria, converted to
glyoxalate, absorbed and then oxidised to oxalate with the production of hyper-
oxaluria. Dowling and his colleagues fed cholyl glycine labelled with radio-active
carbon to control subjects and patients after ileectomy. The amount of radio-active
carbon dioxide recovered from the breath of those with ileectomy was much
increased when compared with the control subjects, but in both groups the amount
of the dose of labelled cholyl glycine excreted in the urine as oxalate was the
same. This would appear to exclude the excess bile salt glycine as the precursors
of the excessive amounts of urinary oxalate.
It has also been suggested that after ileal resection the increased drain on hepatic
glycine for bile salt conjugation might be met by an increased conversion of
glycollate through glyoxalate to glycine. However, Dowling and his colleagues
showed that after the intravenous injection of glyoxalate labelled with radio-active
carbon the conversion to bile salt glycine, carbon dioxide and urinary oxalate was
the same in the controls as in the patients with ileal resection and hyperoxaluria.
They also fed oxalate labelled with radio-active carbon to normal controls and
to patients with an ileectomy with and without hyperoxaluria. In the controls
28 per cent of the radio-active oxalate was recovered from the urine in the first
36 hours, 29 per cent was recovered from the patients with ileectomy without
hyperoxaluria and 52 per cent over the same period from those with an ileectomy
with hyperoxaluria. This suggested strongly that the hyperoxaluria following
ileectomy was the result of an increased absorption of oxalate from the bowel.
Finally, Dowling and his co-workers confirmed this hypothesis by the demonstra-
tion that if the oxalate was removed from the diet of those patients with hyper-
oxaluria excessive urinary excretion of oxalate ceased.
Why some patients with an ileal resection should absorb excessive amounts of
oxalate from the diet and others should not remains in doubt and there is still
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that cholestyramine will decrease the excretion of oxalate in patients with the
short gut syndrome, and as yet it is far from clear why an ion-exchange resin
should block the absorption of oxalate from the bowel.
Before we leave the short gut syndrome we must not forget the possibility that
patients with ileal resection seem to be more prone to the malabsorption of
essential substances than even those with the coeliac syndrome. In the past we have
concentrated too much on the recognised vitamins and have attributed any
unexplained symptoms to their lack. However, Press and his colleagues (1972)
have shown that in patients with ileal resection the percentage of essential fatty
acids in the lecithin, triglyceride and cholesterol ester in fasting plasma is lower
than in normal persons. It has been shown that a deficiency of essential fatty acids
can cause diarrhoea and dermatitis in human infants and in one of Press'
patients with low levels of linoleic acid in the blood fats and a severe dermatitis
the intravenous administration of "intralipid" cured the skin lesions. There is also
the interesting observation that deficiency of essential fatty acids leads to the
development of gall stones in hamsters and perhaps the increased incidence of
gall stones in patients with ileal resection is due not only to gall bladder inertia
but also to a shortage of essential fatty acids.
Several attempts have been made to lessen the diarrhoea in patients with the
short gut syndrome. Considerable adaptation occurs with time and the diarrhoea
and steatorrhoea tend to decrease as the remnant of bowel hypertrophies. In those
in whom the diarrhoea persists probably the most useful regime is the substitution
of medium chain triglycerides for the long chain fats in the normal diet (Zurier
et al, 1966). These medium chain triglycerides can be absorbed without prior
emulsification and solublisation by bile salts and they form a useful source of
calories and decrease the steatorrhoea. An interesting feature of the treatment is
that the steatorrhoea and diarrhoea does not decrease for a week or ten days after
the treatment has begun. At the moment there is no clear explanation why this
should be so, but it could be due to a gradual reduction in the amount of irritating
long chain fatty acids being delivered to the colon. It is important to know that
improvement takes time because the slow response may lead to the treatment being
abandoned prematurely because it appears to be unhelpful.
Sometimes treatment with oral bile acids will reduce the diarrhoea, but in my
experience more commonly the cathartic effect of the bile salts potentiates the
diarrhoea without reducing the steatorrhoea appreciably. Oxbile in a dose of 3-6
gms. daily seems the best preparation to use but I have not had much success
with it myself.
Calcium carbonate has also been used in the treatment of patients with ileal
resection (LeVeen et al, 1967). The rationale of its use is that the calcium carbonate
forms non-irritating soaps with free fatty acids, but to be effective the dose may
have to be very large, up to 30 gms. a day, and there is a danger of the development
of the milk-alkali syndrome. As an alternative cholestyramine can be used. It acts
by binding bile salts within the lumen of the intestine and it may reduce the
diarrhoea but at the cost of aggravating the deficiency of bile salts still further
and making the absorption of fat even more difficult.
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chain fats in the diet offers the most physiological approach to a difficult problem
and if they are introduced slowly the fat intake can usually be built up to a level
that provides enough calories for adequate nutrition.
The medium chain triglycerides are useful in other forms of malabsorption also.
They are helpful in children with fibrocystic disease and in those with biliary
atresia. They have a place in the treatment of patients with a contaminated bowel
syndrome when this is not amenable to surgery, they have revolutionised the
management of a number of rare forms of malabsorption including a /8-lipoprotein-
aemia in which the sufferer is unable to form chylomicrons and they can reduce
the gross steatorrhoea of patients with intestinal lymphangiectasia. They have also
proved helpful in children with steatorrhoea resulting from disaccharidase deficiency
(Gracey et al, 1970).
The final topic 1 wish to consider is the relationship of drugs to malabsorption.
Today the clinician is becoming increasingly aware of the toxic effects of drugs
and the gastro-intestinal tract has not escaped unscathed. The classical example is
the malabsorption produced by Neomycin. This drug produces a malabsorption of
fat, protein, glucose, d-zylose, cholesterol, carotine, sodium, calcium, vitamin B1.2
and iron. The effect can be produced by as little as 3 g. a day. Neomycin induces
morphological changes in the mucosa, precipitates bile salts, inhibits intra-luminal
hydrolysis of long chain triglycerides presumably by inhibiting pancreatic lipase.
It also reduces intestinal lactase activity and lowers serum cholesterol possibly by
blocking cholesterol synthesis within intestinal crypts or by interfering with its
absorption. Neither steroids nor a gluten-free diet improves the malabsorption
induced by Neomycin. Neomycin is not the only drug which can bring about
malabsorption. Other antibiotics, notably tetracycline, Kanamycin, Polymyxin and
Bacitracin, produce minimal malabsorption in man. Alcohol--an inhibit folate
absorption, anti-convulsants may reduce the absorption of vitamin B12, folate and
also d-zylose. Cathartics in excess can produce steatorrhoea as well as diarrhoea
and malabsorption has resulted from the use of colchicine, PAS, Phenindione,
mannitol and calcium carbonate, while MER 29 (Triparanol) once used in the
treatment of hypercholesterolaemia produced a severe steatorrhoea and a mucosal
lesion indistinguishable from that seen in the coeliac syndrome.
In the gluten enteropathy and other conditions which cause widespread damage
to the small intestine drugs, like other substances, may be involved in the general
malabsorption. The best documented is digitalis which needs to be given in large
doses if a therapeutic level is to be attained (Heizer et al, 1971) but no doubt
others are similarly affected. Finally, there are other even more complex ways
in which drugs may interfere with the normal processes of absorption. For example,
calcium is necessary for the absorption of vitamin B,2 and vitamin B12 deficiency
itself may contribute to its own malabsorption (Chanarin, 1971). Enzymes induction
may lead to malabsorption more often than has been realised. Recently, it has been
shown that anti-convulsant drugs induce hepatic enzymes which lead to the
inactivation of vitamin D with the consequent failure of absorption of calcium
and osteomalacia (Richens and Rowe, 1970). The possible interactions are legion
and in the future, just as we have to consider a failure of secretion of intestinal
hormones when we are faced with an unexplained clinical situation in a patient
72with malabsorption, so I think will we have to consider that the clue to the
problem or the source of the trouble may lie on the treatment chart at the foot
of the bed.
The small bowel is a difficult organ to study even today. The gluten enteropathy,
Crohn's disease and other states of malabsorption are nature's experiments in the
physiology and pathology of intestinal function. They still have much to teach us
and if, like the Prince of Serandib, we can see when we are not looking then each
time we treat one of these patients we may be able to add a little to our knowledge
of this fascinating field.
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